|
|
|
|
|
|
|
|
"Medicare reimbursement has been a point of concern for the company. As previously covered in PGx Reporter sister publication ProteoMonitor, there have been reports that Medicare has been denying OVA1 claims at a rate of more than 80 percent (PM 12/23/2011)."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.